HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Stada Health Report 2019: A Quarter Of Europeans Take Supplements, France and Germany Sceptical About Health Gadgets

Executive Summary

Highlights from Stada's 2019 Group Health Report: Over a quarter of Europeans take a daily vitamin or nutritional supplement, four out of 10 people are open to health apps and gadgets, and over a quarter still turn to homemade remedies rather than OTC medicines. 

You may also be interested in...



Germany's Wellness Market 2018: Online, Vitamins and Probiotics Drive Growth

Germany's market for wellness products grew by 6.5% to €2.08bn in 2018, driven by the country's online sales channel, strong sales of vitamin and mineral supplements and a continuing interest in probiotics for digestive health, according to data from market researcher IQVIA.

Stada Seeking OTC Acquisitions After Strong 2018 As Private-Equity Owners Begin To Flex Muscles

Germany's Stada is on the look out for consumer health acquisitions globally that can help it reach its ambition to grow faster than the market in 2019. The firm's new private-equity owners are backing CEO Peter Goldschmidt's plan to take the Branded Products division to the next level.

France's Supplement Market in 2018: Demand For Probiotics and Natural Alternatives Drives Sales Growth

France's food supplements market enjoyed broad-based growth across key categories in 2018, driven by consumer demand for natural alternatives to conventional medicine. Over the 12 months, Pileje overtook Arkopharma as the dominant player in market, as its leading probiotics brand, Symbiosys, flew off the shelves.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148857

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel